Exhibit 10.3


 


VIASYS
HEALTHCARE INC.

AMENDED AND RESTATED 

EMPLOYMENT AGREEMENT


 


THIS AGREEMENT is
made and entered into as of May 26th, 2006 (the “Restatement
Effective Date”), by and among Viasys Healthcare Inc., a Delaware corporation
(together with its successors and assigns permitted under this Agreement, the “Company”),
and Lori J. Cross (the “Executive”).


 


W I T N E S S E T H :


 


WHEREAS, the
Company and the Executive previously entered into an employment agreement dated
as of November 29, 2004 to embody the terms and provisions of the Executive’s
employment (the “Original Agreement”);


 


WHEREAS, the
Company desires that the Executive continue to be employed by the Company and
the Executive is willing to continue to be employed by the Company; and


 


WHEREAS, effective
as of the Restatement Effective Date, the Company and the Executive now desire
to amend and restate the Original Agreement as set forth herein.


 


NOW, THEREFORE, in
consideration of the premises and mutual covenants contained herein and for other
good and valuable consideration, the receipt and sufficiency of which is
mutually acknowledged, the Company and the Executive hereby agree as follows:


 


1.             DEFINITIONS.


 


(a)           “Affiliate”
means a person or other entity that directly or indirectly controls, is
controlled by, or is under common control with the person or other entity
specified.


 


(b)           “Base
Salary” means the salary provided for in Section 4
or any increased salary granted to the Executive pursuant thereto.


 


(c)           “Board”
means the Board of Directors of the Company, or the Compensation Committee or
other applicable committees of the Board of Directors.


 


(d)           “Bonus Plan” means the Company’s management
incentive plan or such other annual bonus plan in existence at the applicable
time.


 


(e)           “Cause”
means the occurrence of any one or more of the following events:


 


(i)            the
Executive’s repeated failure to comply with the reasonable directives of the
relevant senior officers;


 


(ii)           the
Executive’s commission of a felony which is materially and demonstrably
injurious to the Company; or


 


1

















 


(iii)          the
Executive’s continued gross neglect of the Executive’s duties with the Company
(other than any such occurrence resulting from incapacity due to physical or
mental illness).


 


(f)            “Change
in Control” means an event or occurrence set forth in any one or more of
subsections (i) through (iv) below (including, without limitation, an event or
occurrence that constitutes a Change in Control under one of such subsections
but is specifically exempted from another such subsection):


 


(i)            the
acquisition by an individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)) (a “Person”) of beneficial ownership of any capital stock of the Company
if, after such acquisition, such Person beneficially owns (within the meaning
of Rule 13d-3 promulgated under the Exchange Act) 40% or more of either (i) the
then-outstanding shares of common stock of the Company (the “Outstanding
Company Common Stock”), or (ii) the combined voting power of the
then-outstanding securities of the Company entitled to vote generally in the
election of directors (the “Outstanding Company Voting Securities”); provided,
however, that for purposes of this subsection (i), the following acquisitions
shall not constitute a Change in Control:


 


(A)          any
acquisition by the Company, or


 


(B)           any
acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any corporation controlled by the Company;


 


(ii)           the
Continuing Directors (as defined below) do not constitute a majority of the
Board (or, if applicable, the Board of Directors of a successor corporation to
the Company), where the term “Continuing Director” means at any date a member
of the Board (A) who was a member of the Board on the date of the execution of
this Agreement or (B) who was nominated or elected subsequent to such date by
at least a majority of the directors who were Continuing Directors at the time
of such nomination or election or whose election to the Board was recommended
or endorsed by at least a majority of the directors who were Continuing
Directors at the time of such nomination or election; provided, however, that
there shall be excluded from this clause (B) any individual whose initial
assumption of office occurred as a result of an actual or threatened election
contest with respect to the election or removal of directors or other actual or
threatened solicitation of proxies or consents, by or on behalf of a person
other than the Board;


 


(iii)          the
consummation of a merger, consolidation, reorganization, recapitalization or
statutory share exchange involving the Company or a sale or other disposition
of all or substantially all of the assets of the Company in one or a series of
transactions (a “Business Combination”), unless, immediately following such
Business Combination the beneficial owners of the Outstanding Company Common
Stock and Outstanding Company Voting Securities immediately prior to such
Business Combination beneficially own, directly or indirectly, more than 50% of
the then-outstanding shares of common stock and the combined voting power of
the then-outstanding securities entitled to vote generally in the election of
directors, respectively, of the resulting or acquiring corporation in such
Business Combination (which shall include, without limitation, a corporation
which as a result of such transaction owns the Company or substantially all of
the Company’s assets either directly or through one or more


 


2

















 


subsidiaries) (such resulting or acquiring corporation
is referred to herein as the “Acquiring Corporation”); or


 


(iv)          approval
by the stockholders of the Company of a complete liquidation or dissolution of
the Company.


 


(g)           “Code”
means the Internal Revenue Code of 1986, as amended.


 


(h)           “Disability”
or “disabled” means a disability which results in the Executive’s entitlement
to long-term disability benefits under the Company’s applicable long-term
disability plan.


 


(i)            “Equity
Grant” means any compensatory grant of Stock, options with respect to Stock,
restricted Stock, Stock appreciation rights or any other compensatory grant
(whether or not such grant is payable in stock) the value of which is
determined with reference to Stock valuation.


 


(j)            “Notice
of Termination” means a written notice from one party to the other party hereto
given in accordance with Section 24, terminating the Executive’s employment
hereunder.  Any Notice of Termination
shall (i) indicate the specific termination provision hereunder relied on by
the party giving such notice and (ii) to the extent applicable, set forth in
reasonable detail the facts and circumstances providing a basis for termination
of the Executive’s employment under the provision so indicated.  The failure by the Company to set forth any
fact or circumstance that contributes to a showing of Cause shall not waive any
right of the Company hereunder or preclude the Company from asserting any such
fact or circumstance in enforcing its rights hereunder.


 


(k)           “Pro-Rated
Annual Bonus” means an annual cash incentive bonus award for the year in which
the termination occurs, pro-rated through the Termination Date, determined in
accordance with the Bonus Plan and the provisions of Section 5, which award, if
and to the extent so determined to be owed, shall be payable when incentive
awards are normally paid to comparable executives.


 


(l)            “Stock”
means the common stock, $0.01 par value per share, of the Company.


 


(m)          “Termination
Date” means, with respect to any termination of the Executive’s employment
hereunder, the effective date of such termination pursuant to Section 9.


 


2.             TERM
OF EMPLOYMENT.


 


This Agreement,
and all rights and obligations of the parties hereunder, shall take effect upon
the Restatement Effective Date and shall continue until the date that is two
years from the Restatement Effective Date (the “Initial Employment Term”).  In addition, the term of this Agreement shall
automatically renew for periods of two years (each an “Extension Term”) unless
either party gives written notice to the other party, at least ninety (90) days
prior to the end of the Initial Employment Term or at least ninety (90) days
prior to the end of the relevant Extension Term, that the Agreement shall not
be further extended.  The period
commencing on the Restatement Effective Date and ending on the date on which
the term of the Executive’s


 


3

















 


employment
under the Agreement shall terminate is hereinafter referred to as the “Employment
Term.”


 


3.             POSITION,
DUTIES AND RESPONSIBILITIES.


 


(a)           The
Executive is currently employed as Executive Vice President and Group
President, NeuroCare of the Company, and the Executive has been assigned and
shall be assigned such duties and responsibilities as are reasonably consistent
with such position(s), or such other position, duties and responsibilities as
the CEO or the Executive’s direct supervisor from time to time deems
appropriate.


 


(b)           During
the Employment Term, the Executive shall devote the Executive’s entire business
time, attention and energies to the business and interest of the Company in
performing the Executive’s duties and responsibilities under this Agreement,
and to that end but without limitation of the foregoing, the Executive shall
not serve on the board of directors of other corporations or entities without
the prior approval of the Board or the Chief Executive Officer.


 


(c)           Notwithstanding
anything contained in Section 3(b) to the contrary,
nothing herein shall preclude the Executive from (i) serving on the boards of
directors of a reasonable number of trade associations and/or charitable
organizations, (ii) engaging in charitable activities and community affairs,
and (iii) managing the Executive’s personal investments and affairs, provided
that such activities do not materially interfere with the proper performance of
the Executive’s duties and responsibilities as set forth in this Section 3.


 


4.             BASE
SALARY.


 


The Executive
shall be paid an annualized base salary, payable in accordance with the regular
payroll practices of the Company, of $305,000.00, which amount may be increased
from time to time in the discretion of the Board.


 


5.             ANNUAL
CASH INCENTIVE AWARD.


 


During the Employment Term, the Executive shall participate in (a) the
Bonus Plan with a target bonus of 50% of the Base Salary, or such other amount
as may be determined in its discretion by the Board or the appropriate
committee or individual to which authority for these matters has been assigned,
and (b) any other incentive programs established by the Company for its senior
level executives generally.


 


6.             EMPLOYEE
BENEFIT PROGRAMS.


 


During the
Employment Term, the Executive shall be entitled to participate in all employee
pension and welfare benefit plans and programs made available to the Company’s
senior level executives.


 


4

















 


7.             PERQUISITES.


 


During the
Employment Term, the Executive shall be entitled to participate in all of the
Company’s executive perquisites in accordance with the terms and conditions of
such arrangements as are in effect from time to time for the Company’s
senior-level executives.


 


8.             REIMBURSEMENT
OF BUSINESS AND OTHER EXPENSES.


 


The Executive is
authorized to incur reasonable expenses in carrying out the duties and
responsibilities under this Agreement, and the Company shall promptly reimburse
the Executive for such expenses, subject to documentation in accordance with
the Company’s policies.


 


9.             TERMINATION
OF EMPLOYMENT.


 


The Executive’s
employment hereunder shall terminate effective immediately upon the earlier to
occur of the following events:


 


(a)           death
of the Executive;


 


(b)           receipt
by either party of a Notice of Termination for Disability from the other party,
but in any event not until the Executive is determined to be disabled in
accordance with Section 1(h);


 


(c)           the
day the Executive receives a Notice of Termination for Cause from the Company;


 


(d)           the
30th day following receipt by the Executive of a Notice of Termination without
Cause from the Company;


 


(e)           the
30th day following receipt by the Company of a Notice of Termination of
employment from the Executive (other than a Notice of Termination for
non-renewal of the Agreement);


 


(f)            the
90th day following receipt by the Company of a Notice of Termination for
non-renewal of the Agreement from the Executive pursuant to Section 2; and


 


(g)           the
last day of the Employment Term, in the event of receipt by the Executive of a
notice of non-renewal of the Agreement from the Company pursuant to Section 2.


 


10.           RIGHTS
AND REMEDIES UPON TERMINATION OF EMPLOYMENT.


 


(a)           TERMINATION
DUE TO DEATH.  In the event that the
Executive’s employment is terminated due to the Executive’s death, the
Executive’s estate or beneficiaries, as the case may be, shall be entitled to
the following benefits:


 


(i)            The
Executive’s then current Base Salary pro-rated through the Termination Date,
which shall be payable in a lump sum within thirty (30) days of the Termination
Date;


 


5

















 


(ii)           The
Pro-Rated Annual Bonus, if and to the extent payable; and


 


(iii)          Each
Equity Grant held by the Executive, whether or not issued under this Employment
Agreement, that has not vested prior to that date shall immediately vest (and
all relevant vesting restrictions shall lapse) and to the extent subject to an
exercise period, shall remain exercisable until one year following the
Termination Date (but in no event beyond the end of each such Equity Grant’s
otherwise applicable exercise period).


 


(b)           TERMINATION
DUE TO DISABILITY.  In the event that the
Executive’s employment is terminated by either party due to the Executive’s
Disability, the Executive shall be entitled to the following benefits:


 


(i)            Disability
benefits in accordance with the long-term disability (“LTD”) program then in
effect for comparable executives of the Company;


 


(ii)           The
Executive’s then current Base Salary pro-rated through the end of the LTD
elimination period, which shall be payable in a lump sum within thirty (30)
days of the Termination Date;


 


(iii)          The
Pro-Rated Annual Bonus, if and to the extent payable; and


 


(iv)          Each
Equity Grant held by the Executive, whether or not issued under this Employment
Agreement, that has not vested prior to that date shall immediately vest (and
all relevant vesting restrictions shall lapse) and to the extent subject to an
exercise period, shall remain exercisable until one year following the
Termination Date (but in no event beyond the end of each such Equity Grant’s
otherwise applicable exercise period).


 


(c)           TERMINATION
BY THE COMPANY FOR CAUSE.  In the event
that the Company terminates the Executive’s employment for Cause:


 


(i)            The
Executive shall be entitled to receive the Executive’s current Base Salary
pro-rated through the Termination Date, which shall be payable in a lump sum within
thirty (30) days of the Termination Date;


 


(ii)           The
Executive shall not be entitled to any benefits, severance or other
compensation; and


 


(iii)          Each
Equity Grant held by the Executive, whether or not issued under this Employment
Agreement, (A) that has not vested prior to that date shall immediately cease
to vest and shall be forfeited to the Company and cancelled, and (B) that has
vested prior to or on the Termination Date, to the extent subject to an
exercise period, shall remain exercisable for ninety (90) days following the
Termination Date (but in no event beyond the end of each such Equity Grant’s
otherwise applicable exercise period).


 


(d)           TERMINATION BY
THE EXECUTIVE.  In the event of a
termination of employment by the Executive on the Executive’s own initiative,
other than due to (A) death, (B) Disability, (C) the
expiration of the then current Employment Term, or (D) a notice from one party
to the other of its intent not to extend the Employment Term:


 


6

















 


(i)            The
Executive shall be entitled to receive the Executive’s current Base Salary
pro-rated through the Termination Date, which shall be payable in a lump sum within
thirty (30) days of the Termination Date;


 


(ii)           The
Executive shall not be entitled to any benefits, severance or other
compensation; and


 


(iii)          Each
Equity Grant held by the Executive, whether or not issued under this Employment
Agreement, (A) that has not vested prior to that date shall immediately cease
to vest and shall be forfeited to the Company and cancelled, and (B) that has
vested prior to or on the Termination Date, to the extent subject to an
exercise period, shall remain exercisable for ninety (90) days following the
Termination Date (but in no event beyond the end of each such Equity Grant’s
otherwise applicable exercise period).


 


(e)           TERMINATION
WITHOUT CAUSE.  In the event of a
termination of the Executive’s employment by the Company, other than due to (A)
death, (B) Disability, (C) Cause, (D) a notice from one party to the other of
its intent not to extend the Employment Term, the Executive shall be entitled
to the following benefits:


 


(i)            The
Executive’s then current Base Salary pro-rated through the Termination Date,
which shall be payable in a lump sum within thirty (30) days of the Termination
Date;


 


(ii)           An
amount equal to the sum of (A) the Executive’s then current annualized Base
Salary and (B) the most recent cash incentive paid or the target bonus
available under the Bonus Plan, whichever is higher, payable in a lump sum
within ninety (90) days of the Termination Date;


 


(iii)          Continued
participation, at the Company’s expense, in all medical and dental insurance
plans in which the Executive and the Executive’s family were participating on
the Termination Date until the earlier of (A) twelve (12) months following the
Termination Date, or (B) the date or dates on which the Executive receives
substantially equivalent coverage and benefits under the plans of a subsequent
employer; and


 


(iv)          Each
Equity Grant held by the Executive, whether or not issued under this Employment
Agreement, (A) that has not vested prior to that date shall immediately cease
to vest and shall be forfeited to the Company and cancelled, and (B) that has
vested prior to or on the Termination Date, to the extent subject to an
exercise period, shall remain exercisable for ninety (90) days following the
Termination Date (but in no event beyond the end of each such Equity Grant’s
otherwise applicable exercise period).


 


(f)            TERMINATION
DUE TO NON-RENEWAL.  Subject to the first
sentence of Section 10(h), in the event that the Company exercises its right
not to renew this Agreement pursuant to Section 2, the Executive shall be
entitled to the following benefits:


 


(i)            The
Executive’s current Base Salary pro-rated through the Termination Date, which
shall be payable in a lump sum within thirty (30) days of the Termination Date;


 


7

















 


(ii)           The
Pro-Rated Annual Bonus, if and to the extent payable;


 


(iii)          An
amount equal to, in the sole discretion of the Company, either (A) three (3)
months of the Executive’s then current Base Salary, if the Company requests
that the Executive not continue to serve for the remainder of the Employment
Term, or (B) six (6) months of the Executive’s then current Base Salary if the
Company requests that the Executive continue to serve for the remainder of the
Employment Term, subject to the Company’s right to terminate the Executive’s
employment at any time for Cause; with the amount due under this subsection
(iii) to be payable in each case in a lump sum within thirty (30) days of the
Termination Date; and


 


(iv)          Continued participation,
at the Company’s expense, in all medical and dental insurance plans in which
the Executive and the Executive’s family were participating on the Termination
Date until the earlier of (A) three (3) months if the Company requests that the
Executive not continue to serve for the remainder of the Employment Term or six
(6) months if the Company requests that the Executive continue to serve for the
remainder of the Employment Term or (B) the date or dates on which the
Executive receives substantially equivalent coverage and benefits under the
plans of a subsequent employer.


 


(g)           OTHER
TERMINATION BENEFITS.  In the case of any
of the foregoing terminations, to the extent not previously paid or provided or
otherwise contrary to the terms and conditions of this Agreement, the Executive
or the Executive’s estate or beneficiaries, as the case may be, shall also be
entitled to the balance of any incentive awards due the Executive but not yet
paid (including, without limitation, awards due for performance periods that
have been completed, but have not yet been paid), any expense reimbursements
due the Executive, and other benefits, if any, in accordance with applicable
plans or programs of or contracts or agreements of the Executive with the
Company.  In addition, unless indicated
otherwise in this Agreement, the treatment of any options granted to the
Executive in the case of any of the foregoing terminations shall be governed by
the terms of the VIASYS Equity Incentive Plan or other relevant equity compensation
plan or any associated stock option agreement.


 


(h)           CHANGE
IN CONTROL.  If this Agreement is not
renewed by the Company as a result of a Notice of Termination under Section
10(f) (Termination due to Non-Renewal) delivered following a Change in Control,
but only upon the expiration of the Initial Employment Term or the Extension
Term, as applicable, in which the Change of Control occurs, the Company shall
provide to the Executive the benefits described in Section 10(e) (Termination
without Cause) in lieu of the benefits described in Section 10(f), and, in such
event, the Termination Date shall be the last day of the Employment Term.  In addition, in the event of a Change in
Control, the Equity Grants held by the Executive shall be treated in a manner
consistent with the Company’s Equity Incentive Plan, the Executive’s Stock
Option Agreement and this Agreement. 
Notwithstanding anything to the contrary in this Agreement, in the event
the Executive’s employment with the Company is terminated within twelve (12)
months following a Change in Control, the Executive shall be entitled to
benefits equal to the greater of: (i) the benefits due and payable to the
Executive under the change of control plan sponsored by the Company, if any
(the “Change of Control Plan”), or (ii) the benefits due and payable to the
Executive under Section 10 of this Employment Agreement as a result of such
termination.  In furtherance thereof, it
is the parties’ understanding that, in the event of a termination under such
circumstances, the Executive


 


8

















 


shall only be entitled to receive benefits payable
under either the Change in Control Plan or this Employment Agreement (but not
both).


 


(i)            NATURE
OF PAYMENTS.  Any amounts due under this
Section 10 are in the nature of severance payments
considered to be reasonable by the Company and are not in the nature of a
penalty.


 


(j)            NO
MITIGATION; NO OFFSET.  The Executive
shall not be required to mitigate the amount of any payment or benefit provided
in this Section 10 by seeking other employment or
otherwise.  Further, except as provided
in Section 10, the amount of any payment or benefits provided for in this
Section 10 shall not be reduced by any compensation earned by the Executive as
a result of employment by another employer.


 


(k)           RELEASE.  The additional benefits that are not
unconditionally due under applicable law payable to the Executive under this
Section 10 (including but not limited to the benefits payable under
Section 10(e)(ii)) shall be conditioned upon the Executive’s execution of
a Severance Agreement and General Release (substantially in a form that is
acceptable to the Company in its sole discretion (the “Release”)), within ten
(10) business days of the Termination Date or within such longer period
required by law, and such benefits shall not become payable until such time as
the Executive has executed the Release and any revocation period contained in
the Release has expired without the Executive having revoked the Release.  In addition, the Executive’s right to payment
under this Agreement shall cease upon the Executive’s rescission of the Release
or material breach of the Release.


 


11.           CONFIDENTIALITY
& ASSIGNMENT OF INVENTIONS.


 


(a)           The
Executive has previously executed and delivered to the Company the Company’s
standard employee Confidential Information and Invention Assignment Agreement
and acknowledges that the Executive continues to be bound by that agreement.


 


(b)           Upon
the termination of the Executive’s employment, the Executive (or, in the event
of the Executive’s death, the Executive’s personal representative) shall
promptly surrender to the Company the original and all copies of any materials
containing confidential information of the Company which are then in the
Executive’s possession or control; provided, however, that the Executive shall
not be required to surrender the Executive’s rolodexes, personal diaries and
other items of a personal nature.


 


12.           NON-COMPETITION;
NON-SOLICITATION.


 


(a)           The
Executive acknowledges (i) that in the course of the Executive’s employment
with the Company the Executive will become familiar with trade secrets and
customer lists of, and other confidential information concerning, the Company
and its Affiliates, customers and clients and (ii) that the Executive’s
services will be of special, unique and extraordinary value to the Company.


 


(b)           The
Executive agrees that, during the Employment Term and for a period of one year
following the Executive’s termination of employment for any reason (the “Non-Competition
Period”), the Executive shall not in any manner, directly or indirectly, alone
or


 


9

















 


through any person, firm, corporation or enterprise or
as a member of a partnership or as an officer, director, stockholder, investor
or employee of or advisor or consultant to any person, firm, corporation or
enterprise or otherwise, engage or be engaged, or assist any other person,
firm, corporation or enterprise in engaging or being engaged in any Competitive
Activity (as defined below).  For the
purposes of this Section 12, a “Competitive Activity” shall mean, unless
otherwise determined by the Board, a business that (i) is being conducted by
the Company or any Affiliate at the time in question and (ii) was being
conducted, or was under active consideration to be conducted, by the Company or
any Affiliate, at the date of the termination of the Executive’s employment.  It is agreed and understood that the
prohibitions provided for in this Section 12(b) shall not restrict the
Executive from (x) engaging in Restricted Activity for any subsidiary, division
or Affiliate or unit of a company (collectively a “Related Entity”) if that
Related Entity is not engaged in a Competitive Activity, irrespective of
whether some other Related Entity of that company engages in what would
otherwise be considered to be a Competitive Activity (as long as Executive does
not engage in Restricted Activity for such other Related Entity); or (y)
providing services to a business that is engaged in a Competitive Activity
determined with respect to the Company generally but not with respect to the
NeuroCare division of the Company, as determined by the Company in its
reasonable discretion.


 


(c)           The
Executive further agrees that during the Non-Competition Period the Executive
shall not (i) in any manner, directly or indirectly, solicit or recruit (or
attempt to solicit or recruit) any employee of or advisor or consultant to the
Company or its Affiliates to terminate such person’s employment or advisor or
consultant relationship with the Company or its Affiliates, work for a person
other than the Company or its Affiliates, work as an independent contractor, or
engage in any activity that would cause any such employee, advisor or
consultant to violate any agreement with the Company or its Affiliates; (ii) in
any manner, directly or indirectly, hire or cause to be hired any employee of
or advisor or consultant to the Company or any of its Affiliates for any
purpose or in any capacity whatsoever; or (iii) in connection with any business
to which Section 12(b) applies, call on, service, solicit or otherwise do
business with any customer of the Company or any of its Affiliates; provided,
however, that the restriction contained in clause (iii) of this Section 12(c)
shall not apply to, or interfere with, the proper performance by the Executive
of the duties and responsibilities under Section 3 of this Agreement.


 


(d)           Nothing
in this Section 12 shall prohibit the Executive from being a passive owner of
not more than two percent (2%) of the outstanding common stock, capital stock
and equity of any firm, corporation or enterprise so long as the Executive has
no active participation in the management or business of such firm, corporation
or enterprise.


 


(e)           If
the restrictions stated herein are found by a court to be unreasonable, the
parties hereto agree that the maximum period, scope or geographical area
reasonable under such circumstances shall be substituted for the stated period,
scope or area and that the court shall revise the restrictions contained herein
to cover the maximum period, scope and area permitted by law.


 


(f)            If
the Executive violates any provision of Section 12, the restrictions of the
applicable provision shall continue to apply for an additional period of one
year after the date of such violation.


 


10

















 


13.           REMEDIES.


 


Each of the
parties to this Agreement shall be entitled to enforce its rights under this
Agreement specifically, to recover damages and costs (including, without
limitation, reasonable attorney’s fees) caused by any breach of any provision
of this Agreement and to exercise all other rights existing in its favor.  The parties
hereto agree and acknowledge that money damages would not be an adequate remedy
for any breach of the provisions of this Agreement and that any party may in
its sole discretion apply to any court of law or equity of competent
jurisdiction (without posting any bond or deposit) for specific performance
and/or other injunctive relief in order to enforce or prevent any violations of
the provisions of this Agreement. 
Nothing in this Section 13 is intended to prevent the parties from
raising any and all defenses with respect to the necessity for, and scope of,
such injunctive or equitable relief.


 


14.           RESOLUTION
OF DISPUTES.


 


Subject to the
provisions of Section 13 regarding specific performance and/or injunctive
relief, any disputes arising under or in connection with this Agreement or the
Executive’s employment or termination of employment shall be resolved by
binding arbitration, to be held in Philadelphia, Pennsylvania, in each case in
accordance with the National Rules for the Resolution of Employment Disputes of
the American Arbitration Association. 
Judgment upon the award rendered by the arbitrator(s) may be entered in
any court having jurisdiction thereof. 
To the extent permitted by applicable law and rules, the Executive and
the Company shall share equally in the administrative costs and fees of any
arbitration, including the arbitrators’ compensation, except that the party
requesting arbitration shall be solely responsible for the applicable filing
fees and costs.


 


15.           EXPENSES.


 


Subject to the
provisions of Sections 13 and 14, in the event any party hereto seeks a
judicial adjudication of, or an award in arbitration to enforce, the party’s
rights under, or to recover damages for the breach of, this Agreement, the
prevailing party shall be entitled to recover from the other party or parties,
as the case may be, any and all costs actually and reasonably incurred by the
prevailing party in such judicial adjudication or arbitration, including,
without limitation, reasonable attorney’s fees, but only to the extent the
party prevails in such proceeding.


 


16.           ASSIGNABILITY;
BINDING NATURE.


 


This Agreement
shall be binding upon and inure to the benefit of the parties and their
respective successors, heirs (in the case of the Executive) and assigns.  Rights or obligations of the Company under
this Agreement may be assigned or transferred by the Company pursuant to a
merger or consolidation in which the Company is not the continuing entity, or
the sale or liquidation of all or substantially all of the assets of the
Company, provided that the assignee or transferee is the successor to all or
substantially all of the assets of the Company and such assignee or transferee
assumes the liabilities, obligations and duties of the Company, as contained in
this Agreement, either contractually or as a matter of law.  The Company further agrees that, in the event
of a sale of assets or liquidation as described in the preceding sentence, it


 


11

















 


shall
take whatever action it reasonably can in order to cause such assignee or
transferee to expressly assume the liabilities, obligations and duties of the
Company hereunder.  No rights or
obligations of the Executive under this Agreement may be assigned or
transferred by the Executive other than the Executive’s rights to compensation
and benefits, which may be transferred only by will or operation of law.  In the event of a Change in Control, the
Company shall require any successor to the Company or any acquiror of all or
substantially all the Company’s assets to assume and honor the Agreement.


 


17.           REPRESENTATIONS
AND WARRANTIES.


 


(a)           The
Company represents and warrants that it has all requisite corporate power and
authority to enter into this Agreement and that the performance by the Company
of its obligations under this Agreement will not violate any agreement to which
it is a party.


 


(b)           The
Executive represents that the execution of this Agreement by the Executive and
the performance by the Executive of the obligations hereunder will not violate
any agreement to which the Executive is a party.


 


(c)           The
Executive hereby represents and warrants that the Executive is not bound by the
terms of any agreement with any previous employer or other party to refrain
from competing, directly or indirectly, with the business of such previous
employer or any other party.  The
Executive further represents and warrants that Executive’s performance of all
the terms of this Agreement and as an employee of the Company does not and will
not breach any agreement to keep in confidence proprietary information,
knowledge or data acquired by the Executive in confidence or in trust prior to
Executive’s employment with the Company. 
The Executive will not disclose to the Company or induce the Company to
use any confidential or proprietary information or material belonging to any
previous employer or others.  The
Executive will not hereafter grant anyone any rights inconsistent with the
terms of this Agreement.


 


18.           ENTIRE
AGREEMENT.


 


This Agreement
contains the entire understanding and agreement between the parties concerning
the subject matter hereof and supersedes all prior agreements, understandings,
discussions, negotiations and undertakings, whether written or oral, between
the parties with respect thereto, including, without limitation, the Original
Agreement.  This is an integrated
document.


 


19.           AMENDMENT
OR WAIVER.


 


No provision in
this Agreement may be amended unless such amendment is agreed to in writing and
signed by the Executive and an authorized officer of the Company, other than
the Executive.  No waiver by either party
of any breach by the other party of any condition or provision contained in
this Agreement to be performed by such other party shall be deemed a waiver of
a similar or dissimilar condition or provision at the same or any prior or
subsequent time.  Any such waiver must be
in writing and signed by the Executive or an authorized officer of the Company,
other than the Executive, as the case may be.


 


12

















 


20.           SEVERABILITY.


 


In the event that
any provision or portion of this Agreement shall be determined to be invalid or
unenforceable for any reason, in whole or in part, the remaining provisions of
this Agreement shall be unaffected thereby and shall remain in full force and
effect to the fullest extent permitted by law so as to achieve the purposes of
this Agreement.


 


21.           SURVIVORSHIP.


 


Except as
otherwise expressly set forth in this Agreement, the respective rights and
obligations of the parties hereunder shall survive any termination of the
Executive’s employment.  This Agreement
itself (as distinguished from the Executive’s employment) may not be terminated
by either party without the written consent of the other party.


 


22.           REFERENCES.


 


In the event of
the Executive’s death or a judicial determination of the Executive’s
incompetence, reference in this Agreement to the Executive shall be deemed,
where appropriate, to refer to the Executive’s beneficiary, estate or other
legal representative.


 


23.           GOVERNING
LAW/JURISDICTION.


 


This Agreement
shall be governed in accordance with the laws of the State of Delaware without
reference to principles of conflict of laws.


 


24.           NOTICES.


 


All notices and
other communications required or permitted hereunder shall be in writing and
shall be deemed given when (a) delivered personally, (b) sent by certified or
registered mail, postage prepaid, return receipt requested or (c) delivered by
overnight courier (provided that a written acknowledgment of receipt is
obtained by the overnight courier) to the party concerned at the address
indicated below or to such changed address as such party may subsequently give
such notice of:


 


	
  If to the Company:

  	
   

  	
  Viasys Healthcare Inc.

  227 Washington Street, Suite 200

  Conshohocken, PA 19428

  Attn.: General Counsel and Corporate Vice President, Human Resources

  
	
   

  	
   

  	
   

  
	
  If to Executive:

  	
   

  	
  The last known address of the Executive, as provided to the Company
  by the Executive

  



 


25.           HEADINGS.


 


The headings of
the sections contained in this Agreement are for convenience only and shall not
be deemed to control or affect the meaning or construction of any provision of
this Agreement.


 


13

















 


26.           COUNTERPARTS.


 


This Agreement may
be executed in counterparts.


 


[Remainder
of Page Intentionally Left Blank]


 


14

















 


IN WITNESS
WHEREOF, the undersigned have executed this Agreement as of the restatement set
forth above.


 


	
   

  	
  VIASYS HEALTHCARE INC. 

  
	
   

  	
   

  
	
   

  	
  By: 

  
	
   

  	
   

  
	
   

  	
  /s/  Randy H. Thurman

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Name: Randy H. Thurman

  
	
   

  	
  Title: Chief Executive Officer

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  /s/  Lori J. Cross

  	
   

  
	
   

  	
  Lori J. Cross

  



 


15